investorscraft@gmail.com

Intrinsic ValueKoken Ltd. (7963.T)

Previous Close¥1,901.00
Intrinsic Value
Upside potential
Previous Close
¥1,901.00

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Koken Ltd. operates in the healthcare sector, specializing in occupational personal protective equipment and environmental quality improvement solutions. The company’s diversified portfolio includes clean air systems, antibacterial agents, respirators, and protective gear, catering to both industrial and consumer markets. Its Mask-Related Business and Environmental-Related Businesses segments highlight a focus on hygiene and safety, positioning Koken as a key player in Japan’s medical devices industry. The company leverages its long-standing expertise, established in 1943, to maintain a strong market presence, particularly in disaster preparedness and contamination control. Its innovative products, such as the KOACH clean zone creator and IMADEZE antibacterial agent, demonstrate a commitment to technological advancement and regulatory compliance. Koken’s dual focus on industrial and consumer applications provides resilience against market fluctuations, though competition in the protective equipment space remains intense.

Revenue Profitability And Efficiency

Koken reported revenue of JPY 10.76 billion for the period, with net income of JPY 722 million, reflecting a modest but stable profitability margin. Operating cash flow stood at JPY 666 million, indicating efficient working capital management. Capital expenditures of JPY -221 million suggest disciplined investment in growth initiatives, though the company maintains a conservative approach to expansion.

Earnings Power And Capital Efficiency

The company’s diluted EPS of JPY 146.04 underscores its ability to generate earnings per share effectively. With a market capitalization of JPY 8.25 billion, Koken’s capital efficiency is balanced, supported by its niche focus in protective equipment. The low beta of 0.094 indicates minimal correlation with broader market volatility, reflecting its defensive positioning.

Balance Sheet And Financial Health

Koken’s balance sheet shows JPY 2.53 billion in cash and equivalents against total debt of JPY 5.18 billion, suggesting moderate leverage. The company’s liquidity position appears manageable, though debt levels warrant monitoring. Its asset-light model, evidenced by controlled capital expenditures, supports financial stability.

Growth Trends And Dividend Policy

Growth trends remain steady, driven by demand for safety and hygiene products. The dividend per share of JPY 35 reflects a shareholder-friendly policy, though payout ratios are conservative. Future growth may hinge on expanding its product line and geographic reach beyond Japan.

Valuation And Market Expectations

With a market cap of JPY 8.25 billion, Koken trades at a valuation reflective of its niche market role. Investors likely price in stable demand for its products, though limited international exposure may cap upside potential. The low beta suggests it is viewed as a defensive holding.

Strategic Advantages And Outlook

Koken’s strategic advantages lie in its specialized product offerings and entrenched market position. The outlook remains stable, supported by regulatory tailwinds in workplace safety. However, diversification into new markets or technologies could enhance long-term growth prospects.

Sources

Company filings, Bloomberg

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount